No insider purchase over the last 90 days. The latest, by PARRISH MARK W, was filed 12 Aug 2020.
Mylan II B.V. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Nothing new has been filed by managers of Mylan II B.V. in twelve months, the latest record being from 18 November 2020.
Since 2016, the database holds 14 purchases and 14 sales by insiders of the company.
Elsewhere in the same market, our signals recently picked up insider purchases at Applied Digital Corp. and Heico Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
25 of 330 declarations
Mylan II B.V. is a pharmaceutical company focused on the production of generic drugs and health products. It is listed on NASDAQ under the symbol XNAS.
Purchases our model currently ranks for the recommendations list.
All recommendations